Evaluation of AFP, AFP-L3%, and DCP in the diagnosis and after surgery prognosis of HCC

Author:

GU Lei1ORCID,YAN Lei1,BO Lin2,SUI Xuemei1

Affiliation:

1. Affiliated Huai'an No1 People's Hospital of Nanjing Medical University: Huaian First People's Hospital

2. Second Affiliated Hospital of Soochow University

Abstract

Abstract Background To investigate the prognostic value of alpha-fetoprotein (AFP), ratio (AFP-L3%), and Des-γ-carboxyprothrombin (DCP) in the diagnosis and surgical resection of hepatocellular carcinoma (HCC). Methods Normal physical examiners were used as the control group, and the group of HCC patients admitted to our hospital was subdivided into HCC before treatment (HCC-BT) and HCC after excisional surgery (HCC-AS), based on the results of serum AFP, AFP-L3% and DCP assays. The diagnostic value of AFP, AFP-L3%, DCP, and their combinations in the diagnosis of HCC and prognosis of HCC after excisional surgery were compared and analyzed by applying the subject's receive operating characteristic (ROC) and area under the curve (AUC). Results There were 150 cases in the control group and 227 cases in the patient group, of which 89 and 138 cases were HCC-BT and HCC-AS, respectively (35 cases had recurred or new lesions were seen again), and the detection results of all indexes were statistically significant. ROC curve analysis showed that AFP, AFP-L3%, DCP, and their combinations showed a large difference in distinguishing HCC-BT from HCC-AS. AFP, AFP-L3%, and DCP had a high diagnostic value for screening HCC-BT, and DCP was slightly better than AFP and AFP-L3%, with a corresponding AUC of 0.74. When compared to normal controls, DCP, AFP, and AFP-L3% had no diagnostic significance for HCC-AS. Based on the temporary absence of recurrence after surgery as a control, DCP, AFP, and AFP-L3% again showed some prognostic value, and DCP was slightly better than AFP and AFP-L3%, with a corresponding AUC of 0.744. Conclusion In the diagnosis of HCC-BT, AFP, DCP and their combinations have high diagnostic values, and the combined test of the two has higher diagnostic value. In terms of HCC-AS prognosis, both AFP and DCP can be used as the main indicators of prognosis, but it is appropriate to establish new diagnostic criteria.

Publisher

Research Square Platform LLC

Reference25 articles.

1. Efficacy of a surveillance program for early detection of hepatocellular carcinoma;Zoli M;Cancer,1996

2. Department of Medical Administration, National Health and Health Commission of the People's Republic of China. [Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)]. Zhonghua Gan Zang Bing Za Zhi. 2020 Feb 20;28(2):112–128. Chinese. doi: 10.3760/cma.j.issn.1007-3418.2020.02.004. PMID: 32164061.

3. DCP and AFP-L3 Are Complementary to AFP in Predicting High-Risk Explant Features: Results of a Prospective Study;Prashant Kotwani W;Clin Gastroenterol Hepatol,2022

4. International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma;Singal AG;Gastroenterology,2021

5. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improve the detection of BCLC early-stage hepatocellular carcinoma;Best J;Z Für Gastroenterologie,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3